nodes	percent_of_prediction	percent_of_DWPC	metapath
Levosimendan—Extrasystoles—Mycophenolic acid—systemic scleroderma	0.0224	0.0255	CcSEcCtD
Levosimendan—Ventricular fibrillation—Lisinopril—systemic scleroderma	0.0222	0.0252	CcSEcCtD
Levosimendan—TNNC1—connective tissue—systemic scleroderma	0.0213	0.176	CbGeAlD
Levosimendan—Ventricular extrasystoles—Mycophenolic acid—systemic scleroderma	0.0209	0.0238	CcSEcCtD
Levosimendan—Ventricular tachycardia—Mycophenolic acid—systemic scleroderma	0.0189	0.0215	CcSEcCtD
Levosimendan—Ventricular extrasystoles—Lisinopril—systemic scleroderma	0.0188	0.0214	CcSEcCtD
Levosimendan—Extrasystoles—Mycophenolate mofetil—systemic scleroderma	0.0177	0.0201	CcSEcCtD
Levosimendan—Ventricular tachycardia—Lisinopril—systemic scleroderma	0.017	0.0193	CcSEcCtD
Levosimendan—Ventricular extrasystoles—Mycophenolate mofetil—systemic scleroderma	0.0165	0.0188	CcSEcCtD
Levosimendan—Ventricular tachycardia—Mycophenolate mofetil—systemic scleroderma	0.0149	0.0169	CcSEcCtD
Levosimendan—TNNC1—tendon—systemic scleroderma	0.0146	0.121	CbGeAlD
Levosimendan—KCNJ8—smooth muscle tissue—systemic scleroderma	0.0146	0.121	CbGeAlD
Levosimendan—Atrial fibrillation—Mycophenolic acid—systemic scleroderma	0.0145	0.0164	CcSEcCtD
Levosimendan—Cardiac failure—Mycophenolic acid—systemic scleroderma	0.014	0.016	CcSEcCtD
Levosimendan—Hypokalaemia—Leflunomide—systemic scleroderma	0.0131	0.0149	CcSEcCtD
Levosimendan—Atrial fibrillation—Lisinopril—systemic scleroderma	0.013	0.0148	CcSEcCtD
Levosimendan—TNNC1—lung—systemic scleroderma	0.0128	0.106	CbGeAlD
Levosimendan—Hypokalaemia—Mycophenolic acid—systemic scleroderma	0.0125	0.0142	CcSEcCtD
Levosimendan—PDE3A—smooth muscle tissue—systemic scleroderma	0.0117	0.0964	CbGeAlD
Levosimendan—Atrial fibrillation—Mycophenolate mofetil—systemic scleroderma	0.0114	0.013	CcSEcCtD
Levosimendan—Cardiac failure—Mycophenolate mofetil—systemic scleroderma	0.0111	0.0126	CcSEcCtD
Levosimendan—Tachycardia—Pentoxifylline—systemic scleroderma	0.011	0.0125	CcSEcCtD
Levosimendan—KCNJ8—tendon—systemic scleroderma	0.011	0.0907	CbGeAlD
Levosimendan—Hypotension—Pentoxifylline—systemic scleroderma	0.0106	0.012	CcSEcCtD
Levosimendan—Insomnia—Pentoxifylline—systemic scleroderma	0.0102	0.0116	CcSEcCtD
Levosimendan—Hypokalaemia—Mycophenolate mofetil—systemic scleroderma	0.00984	0.0112	CcSEcCtD
Levosimendan—Constipation—Pentoxifylline—systemic scleroderma	0.00966	0.011	CcSEcCtD
Levosimendan—KCNJ8—lung—systemic scleroderma	0.00962	0.0796	CbGeAlD
Levosimendan—Cardiac disorder—Leflunomide—systemic scleroderma	0.00922	0.0105	CcSEcCtD
Levosimendan—KCNJ11—tendon—systemic scleroderma	0.00894	0.0739	CbGeAlD
Levosimendan—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.00879	0.01	CcSEcCtD
Levosimendan—PDE3A—tendon—systemic scleroderma	0.00875	0.0724	CbGeAlD
Levosimendan—Mental disorder—Leflunomide—systemic scleroderma	0.0087	0.0099	CcSEcCtD
Levosimendan—Malnutrition—Leflunomide—systemic scleroderma	0.00865	0.00984	CcSEcCtD
Levosimendan—Angiopathy—Mycophenolic acid—systemic scleroderma	0.0086	0.00978	CcSEcCtD
Levosimendan—Tachycardia—Captopril—systemic scleroderma	0.00836	0.00951	CcSEcCtD
Levosimendan—Mental disorder—Mycophenolic acid—systemic scleroderma	0.0083	0.00944	CcSEcCtD
Levosimendan—Malnutrition—Mycophenolic acid—systemic scleroderma	0.00825	0.00938	CcSEcCtD
Levosimendan—Hypotension—Captopril—systemic scleroderma	0.008	0.0091	CcSEcCtD
Levosimendan—Insomnia—Captopril—systemic scleroderma	0.00774	0.00881	CcSEcCtD
Levosimendan—Angiopathy—Lisinopril—systemic scleroderma	0.00774	0.00881	CcSEcCtD
Levosimendan—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00773	0.00879	CcSEcCtD
Levosimendan—PDE3A—lung—systemic scleroderma	0.00768	0.0635	CbGeAlD
Levosimendan—Cardiac failure—Prednisone—systemic scleroderma	0.00751	0.00854	CcSEcCtD
Levosimendan—Mental disorder—Lisinopril—systemic scleroderma	0.00748	0.00851	CcSEcCtD
Levosimendan—Dizziness—Pentoxifylline—systemic scleroderma	0.00747	0.0085	CcSEcCtD
Levosimendan—Malnutrition—Lisinopril—systemic scleroderma	0.00743	0.00845	CcSEcCtD
Levosimendan—Constipation—Captopril—systemic scleroderma	0.00732	0.00833	CcSEcCtD
Levosimendan—Vomiting—Pentoxifylline—systemic scleroderma	0.00718	0.00817	CcSEcCtD
Levosimendan—Headache—Pentoxifylline—systemic scleroderma	0.00708	0.00805	CcSEcCtD
Levosimendan—Hypotension—Azathioprine—systemic scleroderma	0.00698	0.00794	CcSEcCtD
Levosimendan—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00694	0.0079	CcSEcCtD
Levosimendan—Nervous system disorder—Leflunomide—systemic scleroderma	0.00692	0.00787	CcSEcCtD
Levosimendan—Tachycardia—Leflunomide—systemic scleroderma	0.00689	0.00783	CcSEcCtD
Levosimendan—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00679	0.00772	CcSEcCtD
Levosimendan—Nausea—Pentoxifylline—systemic scleroderma	0.00671	0.00763	CcSEcCtD
Levosimendan—Diarrhoea—Mometasone—systemic scleroderma	0.00667	0.00759	CcSEcCtD
Levosimendan—Hypokalaemia—Prednisone—systemic scleroderma	0.00667	0.00759	CcSEcCtD
Levosimendan—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.0066	0.00751	CcSEcCtD
Levosimendan—Hypotension—Leflunomide—systemic scleroderma	0.00659	0.0075	CcSEcCtD
Levosimendan—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00657	0.00747	CcSEcCtD
Levosimendan—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00655	0.00745	CcSEcCtD
Levosimendan—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00651	0.00741	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00645	0.00734	CcSEcCtD
Levosimendan—Insomnia—Leflunomide—systemic scleroderma	0.00638	0.00726	CcSEcCtD
Levosimendan—Hypotension—Mycophenolic acid—systemic scleroderma	0.00629	0.00716	CcSEcCtD
Levosimendan—Vomiting—Mometasone—systemic scleroderma	0.0062	0.00705	CcSEcCtD
Levosimendan—Headache—Mometasone—systemic scleroderma	0.00611	0.00695	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00609	0.00693	CcSEcCtD
Levosimendan—Insomnia—Mycophenolic acid—systemic scleroderma	0.00609	0.00693	CcSEcCtD
Levosimendan—Constipation—Leflunomide—systemic scleroderma	0.00603	0.00686	CcSEcCtD
Levosimendan—Tachycardia—Lisinopril—systemic scleroderma	0.00592	0.00673	CcSEcCtD
Levosimendan—Diarrhoea—Captopril—systemic scleroderma	0.00586	0.00666	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00581	0.00661	CcSEcCtD
Levosimendan—Nausea—Mometasone—systemic scleroderma	0.00579	0.00659	CcSEcCtD
Levosimendan—Constipation—Mycophenolic acid—systemic scleroderma	0.00576	0.00655	CcSEcCtD
Levosimendan—Hypotension—Lisinopril—systemic scleroderma	0.00567	0.00645	CcSEcCtD
Levosimendan—Dizziness—Captopril—systemic scleroderma	0.00566	0.00644	CcSEcCtD
Levosimendan—Insomnia—Lisinopril—systemic scleroderma	0.00548	0.00624	CcSEcCtD
Levosimendan—Vomiting—Captopril—systemic scleroderma	0.00544	0.00619	CcSEcCtD
Levosimendan—Headache—Captopril—systemic scleroderma	0.00536	0.0061	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00524	0.00596	CcSEcCtD
Levosimendan—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00521	0.00593	CcSEcCtD
Levosimendan—Constipation—Lisinopril—systemic scleroderma	0.00519	0.0059	CcSEcCtD
Levosimendan—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00519	0.0059	CcSEcCtD
Levosimendan—Diarrhoea—Azathioprine—systemic scleroderma	0.00511	0.00582	CcSEcCtD
Levosimendan—Nausea—Captopril—systemic scleroderma	0.00509	0.00579	CcSEcCtD
Levosimendan—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00496	0.00565	CcSEcCtD
Levosimendan—Dizziness—Azathioprine—systemic scleroderma	0.00494	0.00562	CcSEcCtD
Levosimendan—Diarrhoea—Leflunomide—systemic scleroderma	0.00483	0.00549	CcSEcCtD
Levosimendan—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00481	0.00547	CcSEcCtD
Levosimendan—Vomiting—Azathioprine—systemic scleroderma	0.00475	0.0054	CcSEcCtD
Levosimendan—Headache—Azathioprine—systemic scleroderma	0.00468	0.00533	CcSEcCtD
Levosimendan—Dizziness—Leflunomide—systemic scleroderma	0.00467	0.00531	CcSEcCtD
Levosimendan—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00461	0.00524	CcSEcCtD
Levosimendan—Angiopathy—Prednisone—systemic scleroderma	0.0046	0.00523	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00459	0.00522	CcSEcCtD
Levosimendan—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00454	0.00517	CcSEcCtD
Levosimendan—Vomiting—Leflunomide—systemic scleroderma	0.00449	0.0051	CcSEcCtD
Levosimendan—Dizziness—Mycophenolic acid—systemic scleroderma	0.00445	0.00506	CcSEcCtD
Levosimendan—Mental disorder—Prednisone—systemic scleroderma	0.00444	0.00505	CcSEcCtD
Levosimendan—Nausea—Azathioprine—systemic scleroderma	0.00444	0.00505	CcSEcCtD
Levosimendan—Headache—Leflunomide—systemic scleroderma	0.00442	0.00503	CcSEcCtD
Levosimendan—Malnutrition—Prednisone—systemic scleroderma	0.00441	0.00502	CcSEcCtD
Levosimendan—Vomiting—Mycophenolic acid—systemic scleroderma	0.00428	0.00487	CcSEcCtD
Levosimendan—Headache—Mycophenolic acid—systemic scleroderma	0.00422	0.0048	CcSEcCtD
Levosimendan—Nausea—Leflunomide—systemic scleroderma	0.00419	0.00477	CcSEcCtD
Levosimendan—Diarrhoea—Lisinopril—systemic scleroderma	0.00415	0.00472	CcSEcCtD
Levosimendan—Dizziness—Lisinopril—systemic scleroderma	0.00401	0.00456	CcSEcCtD
Levosimendan—Nausea—Mycophenolic acid—systemic scleroderma	0.004	0.00455	CcSEcCtD
Levosimendan—Cardiac disorder—Methotrexate—systemic scleroderma	0.00393	0.00447	CcSEcCtD
Levosimendan—Vomiting—Lisinopril—systemic scleroderma	0.00386	0.00439	CcSEcCtD
Levosimendan—Angiopathy—Methotrexate—systemic scleroderma	0.00384	0.00437	CcSEcCtD
Levosimendan—Headache—Lisinopril—systemic scleroderma	0.0038	0.00432	CcSEcCtD
Levosimendan—Mental disorder—Methotrexate—systemic scleroderma	0.00371	0.00422	CcSEcCtD
Levosimendan—Malnutrition—Methotrexate—systemic scleroderma	0.00369	0.0042	CcSEcCtD
Levosimendan—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00364	0.00414	CcSEcCtD
Levosimendan—Nausea—Lisinopril—systemic scleroderma	0.0036	0.0041	CcSEcCtD
Levosimendan—Nervous system disorder—Prednisone—systemic scleroderma	0.00353	0.00402	CcSEcCtD
Levosimendan—Tachycardia—Prednisone—systemic scleroderma	0.00351	0.004	CcSEcCtD
Levosimendan—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00351	0.004	CcSEcCtD
Levosimendan—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00338	0.00384	CcSEcCtD
Levosimendan—Headache—Mycophenolate mofetil—systemic scleroderma	0.00333	0.00379	CcSEcCtD
Levosimendan—Insomnia—Prednisone—systemic scleroderma	0.00326	0.00371	CcSEcCtD
Levosimendan—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00316	0.00359	CcSEcCtD
Levosimendan—Constipation—Prednisone—systemic scleroderma	0.00308	0.0035	CcSEcCtD
Levosimendan—Nervous system disorder—Methotrexate—systemic scleroderma	0.00295	0.00336	CcSEcCtD
Levosimendan—Hypotension—Methotrexate—systemic scleroderma	0.00281	0.0032	CcSEcCtD
Levosimendan—Insomnia—Methotrexate—systemic scleroderma	0.00272	0.0031	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.0026	0.00296	CcSEcCtD
Levosimendan—Diarrhoea—Prednisone—systemic scleroderma	0.00246	0.0028	CcSEcCtD
Levosimendan—Dizziness—Prednisone—systemic scleroderma	0.00238	0.00271	CcSEcCtD
Levosimendan—Vomiting—Prednisone—systemic scleroderma	0.00229	0.0026	CcSEcCtD
Levosimendan—Headache—Prednisone—systemic scleroderma	0.00226	0.00257	CcSEcCtD
Levosimendan—Nausea—Prednisone—systemic scleroderma	0.00214	0.00243	CcSEcCtD
Levosimendan—Diarrhoea—Methotrexate—systemic scleroderma	0.00206	0.00234	CcSEcCtD
Levosimendan—Dizziness—Methotrexate—systemic scleroderma	0.00199	0.00226	CcSEcCtD
Levosimendan—Vomiting—Methotrexate—systemic scleroderma	0.00191	0.00218	CcSEcCtD
Levosimendan—Headache—Methotrexate—systemic scleroderma	0.00189	0.00214	CcSEcCtD
Levosimendan—Nausea—Methotrexate—systemic scleroderma	0.00179	0.00203	CcSEcCtD
